Example: Heart Attack

Clinical Trials on Polycystic Liver Disease

Total 19 results

    • NCT04645251
      Not yet recruiting
      Polycystic Liver Disease Registry (UK)
      Conditions: Polycystic Liver Disease
    • NCT01315795
      Completed
      Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease
      Conditions: Polycystic Liver Disease
    • NCT00934791
      Terminated
      Polycystic Liver Disease in Kidney Transplant
      Conditions: Polycystic Liver Disease
    • NCT02173080
      Recruiting
      Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
      Conditions: Polycystic Liver Disease
    • NCT02021110
      Completed
      Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease
      Conditions: Polycystic Liver Disease (PLD):; Polycystic Kidney, Autosomal Dominant; Polycystic Liver Disease
    • NCT01670110
      Completed
      Pasireotide LAR in Severe Polycystic Liver Disease
      Conditions: Somatostatin Analogs; Polycystic Liver Disease; Autosomal Dominant Polycystic Kidney Disease; Autosomal Dominant Polycystic Liver Disease
    • NCT01354405
      Completed
      Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)
      Conditions: Polycystic Liver Disease
    • NCT01157858
      Completed
      Everolimus and LongActing Octreotide Trial in Polycystic Livers
      Conditions: Polycystic Liver Disease
    • NCT00426153
      Completed
      Octreotide in Severe Polycystic Liver Disease
      Conditions: Polycystic Kidney, Autosomal Dominant; Polycystic Liver Disease; Hepatomegaly; Liver Diseases; Kidney, Polycystic; Abdominal Pain
    • NCT03960710
      Recruiting
      Automatic Segmentation of Polycystic Liver
      Conditions: Polycystic Liver Disease; Polycystic Hepatorenal Disease; Liver Injury
    • NCT00565097
      Completed
      Lanreotide as Treatment of Polycystic Livers
      Conditions: Polycystic Liver Disease; Hepatomegaly; Liver Diseases; Polycystic Kidney, Autosomal Dominant
    • NCT04111692
      Recruiting
      A Prospective Observational Study of Foam Sclerotherapy .
      Conditions: Autosomal Dominant Polycystic Kidney; Renal Cyst; Autosomal Dominant Polycystic Liver Disease; Hepatic Cyst
    • NCT00771888
      Unknown status
      Open-Label Extension of LOCKCYST Trial
      Conditions: Polycystic Liver Disease; Hepatomegaly; Liver Diseases; Polycystic Kidney; Autosomal Dominant
    • NCT02506946
      Recruiting
      NAFLD in Adolescents and Young Adults With PCOS
      Conditions: Polycystic Ovary Syndrome; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome
    • NCT02500147
      Suspended
      Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
      Conditions: Polycystic Ovary Syndrome; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome
    • NCT01735799
      Unknown status
      THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS
      Conditions: Polycystic Ovarian Syndrome,; Nonalcoholic Fatty Liver Disease
    • NCT01680250
      Unknown status
      Sirolimus for Massive Polycystic Liver
      Conditions: Polycystic Kidney Diseases
    • NCT01632605
      Completed
      The Vienna RAP Pilot Study
      Conditions: ADPKD
    • NCT03617263
      Recruiting
      Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII)
      Conditions: Non-alcoholic Fatty Liver Disease in Women With PCOS
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations